Document is current
Any future updates will be listed below
-
Authors
Saijo, Ken https://orcid.org/0000-0003-0179-3789
Imai, Hiroo
Kasahara, Yuki
Numakura, Ryunosuke
Ueta, Reio
Sasaki, Keiju
Yoshida, Yuya
Umegaki, Sho
Taniguchi, Sakura
Ouchi, Kota
Komine, Keigo
Shirota, Hidekazu
Takahashi, Masanobu
Ishioka, Chikashi
- License Information
-
More Information
Article History
Received: 9 August 2024
Accepted: 27 March 2025
First Online: 7 April 2025
Declarations
:
: This study was approved by the Ethics Committee of the Faculty of Medicine of Tohoku University School of Medicine (Approval No.2021-1-351) and was performed in accordance with the ethical standards described in the Declaration of Helsinki. Informed consent for this study was obtained using the opt-out system with the approval of the ethics committee.
: Ken Saijo received research funding from Adlai Norty and Takeda Science Foundation. Masanobu Takahashi received research funding from Ono Pharmaceutical and honoraria from Daiichi Sankyo Company, Bristol Myers Squibb, and Ono pharmaceutical. Chikashi Ishioka received research funding from Chugai Pharmaceutical, Taiho Pharmaceutical, Daiichi Sankyo Company, Asahi Kasei Pharma, Bayer Yakuhin, Takeda Pharmaceutical, Ono Pharmaceutical and received honoraria from Chugai Pharmaceutical and Daiichi Sankyo Company, and representatives of the Tohoku Clinical Oncology Research and Education Society, a specified nonprofit corporation. The other authors declare no conflicts of interest.
